RCPHF - Small contractors play pivotal role on vaccine supply chain

Coronavirus vaccine makers have quickly turned to a network of smaller, lesser-known manufacturers to mount an unprecedented effort to produce their shots at a record pace, WSJ reports.While new mRNA technology makes industrialization easier than a traditional vaccine - since manufacturers don't have to work with live pathogens - they still need to ramp up their processes to meet orders for more than a billion doses next year."We're working harder and faster than we ever have," said Ger Brophy, executive vice president at Avantor (AVTR), one of dozens of third-party manufacturers that have been mobilized to make vaccine ingredients. The company's plants have added workers and night shifts to keep up with demand.Warp speed... Lonza (LZAGY) first made contact with Moderna in March, telling the drugmaker that there was a free building at its factory in the Swiss town of Visp that could be used for vaccine manufacturing. Ten months

For further details see:

Small contractors play pivotal role on vaccine supply chain